Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1999
08/10/1999CA2260698A1 Pyrrolidine and piperidine derivatives
08/10/1999CA2093403C Therapeutic agent for parkinson's disease
08/10/1999CA2006529C N-pyridinyl-9h-carbozol-9-amines, a process for their preparation and their use as medicaments
08/09/1999CA2260701A1 Method of preparing substituted quinazolin-4-ones
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038955A2 Mutant herpes simplex viruses and uses thereof
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038876A1 Glycosidation of 4,5-epoxymorphinan-6-ols
08/05/1999WO1999038873A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038869A1 Therapeutic compounds
08/05/1999WO1999038868A1 Azolo triazines and pyrimidines
08/05/1999WO1999038864A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999WO1999038863A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/05/1999WO1999038854A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038843A1 Hydroxamic and carboxylic acid derivatives
08/05/1999WO1999038841A1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
08/05/1999WO1999038534A1 Neurotrophic factor secretion promoters
08/05/1999WO1999038516A1 Neurotrophic properties of ipgs and ipg analogues
08/05/1999WO1999038510A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999WO1999038504A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999WO1999038503A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999WO1999038502A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999WO1999038499A2 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
08/05/1999WO1999038498A1 Method for treating alzheimer's disease
08/05/1999WO1999028493A3 Method for identifying inhibitors of g-protein coupled receptor hibef51
08/05/1999WO1999024398A3 Urea derivatives and their use as integrin inhibitors
08/05/1999WO1999023092A3 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999DE19818001C1 Preparing extract fractions of Hypericum perforatum, for treatment of depression
08/05/1999CA2319833A1 Glycosidation of 4,5-epoxymorphinan-6-ols
08/05/1999CA2319669A1 Mutant herpes simplex viruses and uses thereof
08/05/1999CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999CA2319627A1 Therapeutic compounds
08/05/1999CA2319387A1 Neurotrophic factor secretion promoters
08/05/1999CA2319143A1 Modulation of sodium channels in dorsal root ganglia
08/05/1999CA2318960A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999CA2318921A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999CA2318920A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999CA2318830A1 Derivatives of 1,3,4-oxadiazolone
08/05/1999CA2318817A1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318814A1 Benzoate derivatives of diaryl 1,3,4-oxadiazolone
08/05/1999CA2318738A1 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
08/05/1999CA2318584A1 Neurotrophic properties of ipgs and ipg analogues
08/05/1999CA2317515A1 Oxazole derivatives as serotonin-1a receptor agonists
08/05/1999CA2313226A1 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
08/04/1999EP0932623A1 Colostrinin, and uses thereof
08/04/1999EP0932609A1 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO 2,3-e]INDOL-8-ONE
08/04/1999EP0932600A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1$g(b) CONVERTING ENZYME INHIBITORS
08/04/1999EP0932598A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
08/04/1999EP0932597A1 Use of gamma-hydroxybutyric acid amides in the treatment of drug addiction and in particular of alcoholism
08/04/1999EP0932416A2 Method and potentiated composition for treating migraine
08/04/1999EP0932414A1 USES OF COMPOSITIONS WITH alpha-LACTALBUMEN BASE
08/04/1999EP0932409A1 A method for producing an extract from valeriana officinalis containing high levels of valerenic acid
08/04/1999EP0932407A1 Method for treating migraine pain
08/04/1999EP0932403A1 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
08/04/1999EP0932400A1 Anticonvulsant derivatives useful in treating neuropathic pain
08/04/1999EP0932398A1 Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic-depressive bipolar disorders
08/04/1999EP0932395A1 Methods and compositions employing red yeast fermentation products
08/04/1999EP0932388A2 Dosage form and method for administering drug
08/04/1999EP0854720B1 Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy
08/04/1999EP0848707B1 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof
08/04/1999EP0759027B1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
08/04/1999EP0701555B1 Indazole derivatives
08/04/1999EP0640086B1 MERCAPTOACETYLAMIDO PYRIDAZO[ 1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
08/04/1999CN1225131A Method for treating amyotrophic lateral sclerosis
08/04/1999CN1225085A Substituted pyridines as selective cyclooxygenase-2 inhibitors
08/04/1999CN1224618A Preparation of liver protecting and drunkenness dispelling liquid medicine
08/04/1999CN1224610A Ibuprofen compositions
08/03/1999US5932737 Peptide compounds for treatment of no-mediated diseases
08/03/1999US5932734 N-aminoalkylfluorenecarboxamides
08/03/1999US5932730 Endothelin antagonist
08/03/1999US5932716 Disclosed herein are methods and compositions for identifying morphogen analogs.
08/03/1999US5932701 ribA
08/03/1999US5932599 4-amino-n-(pyridinyl-4-yl)-benzenesulfonamides as active material treating malaria, bacterial infection, neurological disorders
08/03/1999US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors
08/03/1999US5932594 3-substituted piperidine derivative
08/03/1999US5932586 Prostaglandin synthase inhibitors
08/03/1999US5932581 Administering sorbitol dehydrogenase inhibitor
08/03/1999US5932565 Vitamin D analogues
08/03/1999US5932542 Composition and methods using myelin-associated glycoprotein (MAG) and inhibitors thereof
08/03/1999US5932238 Galanthamine containing transdermal applicator for the treatment of alcoholism
08/03/1999CA2182101C Neuroprotective compounds
08/03/1999CA2171561C K-252a derivatives which enhance neurotrophin-induced activity
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999037751A1 Purified populations of stem cells
07/29/1999WO1999037682A2 Antibodies against human il-12
07/29/1999WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037658A1 Ustilipides, method for the production and the use thereof
07/29/1999WO1999037651A1 Chemokine receptor antagonists and methods of use therefor
07/29/1999WO1999037649A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037648A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037647A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037646A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037645A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037644A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
07/29/1999WO1999037637A1 Benzamide derivatives as vasopressin antagonists
07/29/1999WO1999037623A2 Sulphonamide derivatives for treatment of cns disorders
1 ... 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 ... 1833